Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-07-008951
Filing Date
2007-11-23
Accepted
2007-11-23 21:45:01
Documents
1
Period of Report
2006-11-20

Document Format Files

Seq Description Document Type Size
1 c51411_ex.html 4  
1 c51411_ex.xml 4 22612
  Complete submission text file 0000930413-07-008951.txt   24368
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Issuer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address ELITE PHARMACEUTICALS INC 165 LUDLOW AVE NORTHVALE NJ 07647 2017502646
BERK BERNARD (Reporting) CIK: 0001280942 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15697 | Film No.: 071265198